BAKER BROS. ADVISORS LP - 26 Jun 2025 SCHEDULE 13D/A Report for Kymera Therapeutics, Inc. Common Stock, $0.0001 par value per share (KYMR)

Filing Manager
BAKER BROS. ADVISORS LP
Reporting Manager
Baker Bros. Advisors LP
Security
Kymera Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
KYMR
Shares outstanding
70,174,105 shares
Disclosed Ownership
6,666,540 shares
Ownership
9.5%
Form type
SCHEDULE 13D/A
Filing time
30 Jun 2025, 20:26:26 UTC
Date of event
26 Jun 2025
Next filing
11 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"BAKER BROS. ADVISORS LP disclosed 9.5% ownership in Kymera Therapeutics, Inc. Common Stock, $0.0001 par value per share (KYMR) on 26 Jun 2025."

Quick Takeaways

  • BAKER BROS. ADVISORS LP filed SCHEDULE 13D/A for Kymera Therapeutics, Inc. Common Stock, $0.0001 par value per share (KYMR).
  • Disclosed ownership: 9.5%.
  • Date of event: 26 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 30 Jun 2025, 20:26.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Baker Bros. Advisors LP 9.5% 6,666,540 6,666,540 0 /s/ Scott L. Lessing Scott L. Lessing/ President By: Baker Bros. Advisors (GP) LLC, its general partner 0001263508
Baker Bros. Advisors (GP) LLC 9.5% 6,666,540 6,666,540 0 /s/ Scott L. Lessing Scott L. Lessing/ President 0001580575
Julian C. Baker 9.5% 6,666,540 6,666,540 0 /s/ Julian C. Baker Julian C. Baker 0001087939
Felix J. Baker 9.5% 6,666,540 6,666,540 0 /s/ Felix J. Baker Felix J. Baker 0001087940

Sponsored